Objective: To compare composite adverse outcome rate of infants <32 weeks gestational age (GA) who were born after preterm premature rupture of membranes (PPROM) at previable gestation to those born without PPROM.
Introduction
Preterm premature rupture of the membranes (PPROM) complicates 3% of pregnancies and is associated with approximately one third of all preterm births. [1] [2] [3] [4] PPROM between 16 and 26 weeks of gestation is reported at a frequency of 1% in the United States. 1, 5 Despite recent advances in both obstetric and neonatal care, including use of intrapartum antibiotics, antenatal steroids, postnatal surfactant and gentle ventilation strategies, both mother and infant are at high risk of adverse outcomes in situations complicated by PPROM at previable gestational age (GA). 1, 6, 7 Maternal complications include intrauterine infection, oligohydramnios 2, 3, 8, 9 and placental abruption. 9 Neonates are at risk of mortality and morbidities due to pulmonary hypoplasia, extreme difficulty at resuscitation, sepsis, air leaks and chronic lung disease (CLD). 2, 6, 8, [10] [11] [12] In a systematic review and metaanalyses of reports from 1980 to 1999, significant lack of good quality information of outcomes of neonates born after early PPROM was identified. 6 Perinatal survival was reported to be <20% when PPROM occurred at both <20 and between 20 and 23 weeks gestation. On one hand, improved survival has been reported in recent years by some studies 12, 13 whereas others have cautioned against conservative management due to increasing maternal complications rates. 14 Natural history suggests that approximately 75% of women deliver within 1 month of PPROM and that the remaining 25% remain pregnant more than 1 month. 8 The reported neonatal outcomes of such pregnancies that have resulted in viable neonates are variable.
9, 15 The objective of this study was to compare composite outcome (death or severe morbidities) of infants <32 weeks GA who were born after PPROM at previable gestation (<24 weeks GA) of at least 7 days duration with the outcome of those born without PPROM.
Methods

Setting
A retrospective review of prospectively collected data was performed. Data were collected for preterm infants <32 weeks GA discharged (died or survived) between July 2004 and October 2007 at our tertiary care perinatal center in Toronto, Canada. Data related to all neonatal intensive care unit (NICU) admissions (including delivery room deaths) were collected daily prospectively by either staff neonatologists or a trained data abstractor according to strict guidelines and definitions.
Eligibility criteria
In this matched cohort study of preterm infants <32 weeks gestation at birth, we attempted to identify two to three comparable infants for each index case. Cases were infants born with >7 days of PPROM that occurred before 24 weeks GA. Matched cohort consisted of infants born without PPROM. The cohort was matched for GA ( ± 1 week), sex and birth date ( ± 3 months). Infants with congenital anomalies other than positional malformations associated with oligohydramnios, those for whom palliative care was planned antenatally because of extreme prematurity or lethal malformations and those with antenatal diagnoses of chromosomal anomalies, were excluded.
Ethics statement
The database and this study had approval from research ethics board at our institution.
Data collection
The diagnosis of membrane rupture was based on history, the findings of amniotic fluid on sterile speculum examination, positive nitrazine and/or fern test and oligohydramnios, which was defined as an amniotic fluid index of less than five. Patients with history of PPROM were then followed up in our clinic every 2 weeks until they reach GA of 24 weeks and then once weekly until birth. Clinical chorioamnionitis was considered if mother had pyrexia (temperature >38 1C) accompanied by uterine tenderness, purulent vaginal discharge, or fetal tachycardia for no other reason. After the infant's admission to NICU, data regarding daily management and common neonatal outcomes as defined below were collected prospectively in a database and were retrieved for study infants. Information related to daily NICU care, as well as results of head ultrasound, eye examination and clinical status was retrieved from this database and electronic patient records.
Definitions for outcomes
Primary outcome was a composite adverse outcome of mortality or any of three severe morbiditiesFgrade 3 or 4 intraventricular hemorrhage (IVH) or periventricular leukomalacia; severe retinopathy of prematurity (ROP) >stage 2 or CLD at 36 weeks postmenstrual age. Secondary outcomes included mortality in NICU, respiratory distress syndrome, air leak, persistent pulmonary hypertension (PPHN), severe (>grade 3) IVH, CLD, necrotizing enterocolitis, patent ductus arteriosus, nosocomial infections, severe ROP, duration (days) of respiratory support, duration (days) of oxygen treatment, duration of intravenous support and duration of total parenteral nutrition. GA was determined by the best obstetric estimate based on early prenatal ultrasound, obstetric examination and obstetric history. An infant was defined as small for gestational age if the birth weight was less than the third percentile for GA according to the published data for Canadian infants. 16 Clinical Risk Index for Babies (CRIB) score, 17 Score of Acute Neonatal Physiology, version IIFPhysiologic Extension 18 and Transport Risk Index of Physiologic Stability (TRIPS) 19 are neonatal illness severity scores calculated from variables during the first day of admission to the NICU. PPHN was defined as persistent labile hypoxemia (PaO 2 <50 in 100% oxygen) in the absence of structural cardiovascular malformation disproportionate to the degree of pulmonary parenchymal disease and associated with clinical (PaO 2 difference of >15 mm Hg between pre-and postductal values) or echocardiographic evidence of right to left shunting at atrial and/or ductal level, tricuspid regurgitation and elevated right ventricular systolic pressure. CLD was defined as oxygen dependency at 36 weeks corrected GA. 20 IVH was classified in four grades as suggested by Papile et al.;
21 the worst findings on head ultrasound performed at anytime during the stay in NICU was considered for analysis. Necrotizing enterocolitis was defined according to Bell's criteria (stage 2 or higher). 22 Nosocomial infection was defined by isolation of organisms from blood, urine or cerebrospinal fluid culture. Patent ductus arteriosus was diagnosed clinically based on symptoms and signs.
Statistical methods
Sample size was calculated expecting a case/matched cohort ratio of 1:2 to 3, a of 0.05 and power of 80% as well as correlation for exposure (PPROM) between cases and matched cohort of 0.1. Composite adverse outcome rate for the entire cohort was approximately 40% and for an odds ratio (OR) of 4 (four times the odds of mortality and severe morbidities) we needed 25 to 28 cases. Baseline characteristics and common outcomes between groups were compared using w 2 -test, t-test and Mann-Whitney U-test. Logistic regression was performed controlling for GA, sex, small for gestational age, receipt of antenatal steroids, mode of birth and TRIPS score at birth. The SPSS, version 15 (SPSS Inc., Chicago, IL, USA) was used for data analysis.
Results
During the study period, 3479 patients were admitted to our NICU, of which 1051 patients were <32 weeks GA at birth. Twenty-nine infants with PPROM at previable age and of >7 days duration and 74 matched infants were identified (case/matched cohort ratio of 1:2.6). The infants with PPROM (cases) constituted 2.8% of the total number of infants born <32 weeks GA. Two infants had contractures noted at birth and one infant had 'potter-like' facial features.
As shown in Table 1 , there were no significant differences between the groups at birth except for severity of illness scores and incidence of suspected chorioamnionitis, both of which were unfavorable among infants in the PPROM group, and the use of antenatal steroids, with a higher proportion of infants in the PPROM group receiving a complete course compared with the matched cohort. As expected, the duration of rupture of membranes (ROM) and GA at ROM were different between groups (Table 1) . Results of other neonatal outcomes are reported in Table 2 . There was significantly increased risk of mortality or severe morbidities among cases (69 vs 47%; P ¼ 0.02, unadjusted OR 2.5, 95% CI 1.0, 6.1). Logistic regression analyses confirmed PPROM at a previable age to be significantly associated with composite primary outcome (adjusted OR 4.0, 95% CI 1.2, 13.6). Univariate subgroup analysis revealed no significant difference in composite adverse outcome between groups of infants who had PPROM before 20 weeks (n ¼ 12) compared with those who had PPROM after 20 weeks (n ¼ 17) (58 vs 76%; P ¼ 0.42). Reported causes of death among cases (n ¼ 7) were pulmonary hypoplasia in three, candida sepsis in one, bacterial sepsis in one, severe IVH in one and extreme prematurity in one infant.
Oligohydramnios or anhydramnios was present in 17 (63%) cases. For all cases, a course of prophylactic antibiotics, usually 5 days of erythromycin, was used at the time of PPROM in keeping with hospital policy. There was no difference in the risk of composite outcome among those who had oligo-or anhydramnios compared with those who did not have oligo-or anhydramnios. (65 vs 70%). Among the five patients who had anhydramnios, composite outcome was present in four, two patients died, three had severe IVH/periventricular leukomalacia, three had severe ROP and one developed CLD at 36 weeks.
Discussion
Counseling women who present with PPROM at previable GA is challenging. Many of these women will go into spontaneous labor, or will need to be delivered at a previable GA due to maternal health risks. Furthermore, in our local experience, a very poor prognosis for the fetus/neonate is often presented to the patient and termination of pregnancy is frequently recommended. However, in the subset of women who experience PPROM at a previable GA and choose to continue their pregnancy to reach a viable GA, we report a 76% survival to discharge from NICU for their preterm infants born at <32 weeks. In fact, our study may underestimate survival as we restricted our analysis to those infants who were born between 24 and 32 weeks GA. This cohort of preterm infants born following very early PPROM experienced higher rates of combined adverse outcomes including death or severe neurological injury, severe ROP or CLD than matched preterm infants. We acknowledge that our data are from a select group of infants who survived early PPROM and not a population-based cohort of mothers who had ruptured and were serially followed up to assess the outcomes.
Lindner et al., 12 in a retrospective matched cohort study of 19 infants, reported that PPROM before 20 weeks was associated with higher risk of mortality, CLD and air leak when compared with infants not exposed to PPROM. However, the differences were PPROM before age of viability and neonatal outcomes H Soylu et al not statistically significantly different due to lack of power in the study. Similar to our report, initial respiratory morbidities were identified to be significantly worse. However, 68% of infants in their series survived to discharge, a smaller percentage than the 76% reported in our series. Everest et al. 13 in a cohort study of 98 pregnancies complicated by PPROM before 24 weeks reported that 41% resulted in live births. Of these live-born neonates, air leak occurred in 38%, pulmonary hypoplasia was diagnosed in 25 and 70% survived to discharge. CLD was present in 43% of these survivors. Findings from Lindner et al., 12 Everest et al. 13 and our study are in contrast with previous findings. Falk et al. 10 reported that all neonates born between 24 and 28 weeks GA who had PPROM before 20th week GA died whereas survival was 55% if PPROM occurred at 22 to 23 weeks GA. Shumway et al. 9 reported 51% mortality if PPROM occurred between 20 and 24 weeks GA. Winn et al. 23 reported 95% perinatal mortality for neonates with pulmonary hypoplasia associated with PPROM. Morales and Talley 15 reported 40% survival for PPROM <25 weeks GA. Farooqi et al. 7 reported 40% survival if PPROM was at <20 weeks GA. Kilbride et al. 24 reported mortality of >90% if PPROM at <25 weeks GA was associated with oligohydramnios of >14 days. Xiao et al. 25 reported 82% mortality for PPROM <22 weeks. Dinsmoor et al.
1 reported 53% mortality for median GA at PPROM of 22 weeks and median latency of 13 days. Verma et al. 26 reported 82% mortality following PPROM at 18 to 23 weeks GA. It is obvious that there are marked differences in outcomes between studies. This is probably due to heterogeneity in the base population studied, variability in obstetrical practices, differing counseling provided to women and improvement in neonatal outcomes over time.
One of the most common problems after early and prolonged PPROM is pulmonary hypoplasia. 6, 27 Vergani et al. 28 reported ROM of as little as 5 days can interfere with lung maturation. Persistent oligohydramnios, particularly when PPROM occurs before viability, inhibits alveolar development and can lead to lethal pulmonary hypoplasia. 8 The incidence of pulmonary hypoplasia varied between studies from 13 23 to 60%. 7 Pulmonary hypoplasia is primarily a histological diagnosis. The clinical correlates include marked delay in postnatal adaptation leading to PPHN and air leaks. In our study, 21% of the total study infants had PPHN and 17% had air leaks. Our case infants likely had variable degree of alteration in their lung growth and only long-term data from pulmonary function testing among survivors can ascertain whether these infants had an element of decreased lung growth. We did not see differences in the CLD rates between cases and controls. This may be attributed, in part, to the higher mortality among cases, resulting in fewer infants surviving to develop CLD. In survivors, careful pulmonary management (for example, gentle ventilation, permissive hypercapnea) may have decreased the incidence of CLD. The incidence of respiratory distress syndrome was higher in case group despite receipt of prenatal steroids. We used criteria of small lung volume, ground glass appearance with or without air bronchogram and need for FiO 2 >30% as our criteria for diagnosis of respiratory distress syndrome. However, some of these infants may also have component of pulmonary hypertension or prolonged transition to postnatal life.
The latency period between PPROM and birth is suggested as an important determinant for overall outcome of the pregnancy. 28 Winn et al. 23 reported that latency was >4 weeks in the group who had pulmonary hypoplasia whereas it was only 8 days in the group of patients who did not have pulmonary hypoplasia. Farooqi et al. 7 reported an average latency of 70 days and in their series 60% of patients had pulmonary hypoplasia. In our study, the latency was 45 days; however, only 21% of our cases showed some clinical characteristics of pulmonary hypoplasia such as PPHN and air leaks. It is probable that latency is an important determinant; however, we cannot conclude as such from our small sample size.
Oligohydramnios or anhydramnios are also important variables for predicting outcome. 24, 29 Hadi et al. reported 69% mortality for infants of 26 to 34 weeks GA if associated with oligohydramnios. In our series, we did not identify a difference in composite outcome rate between patients born following oligo-and anhydramnios. This may due small number of infants in each group. We also acknowledge that our definition of amniotic fluid index <5 for oligohydramnios may not be strict enough to predict pulmonary hypoplasia.
Strengths of our study include a contemporary matched cohort, unbiased data collection for outcomes and 2 to 3 controls per case. We used a composite adverse outcome of mortality and severe morbidities. This is an important point to consider as these morbidities individually and in combination are associated with adverse neurodevelopmental outcome. 30 We are aware that CLD per se would not deter any woman to terminate pregnancy; however, association of CLD to higher risk of neurodevelopmental outcomes should be explained to mothers when counseling at previable age.
Limitations of our study include lack of long-term follow-up data on these infants. We can only speculate that survivors with morbidities included in adverse outcomes are at higher risk of adverse neurodevelopmental outcomes. Proper long-term outcome data have been a deficit in literature. Serial amnioinfusions has been suggested as one measure to improve perinatal complications associated with PPROM at or before mid-pregnancy. 31 However, controlled studies are needed to assess efficacy and safety of such intervention. Long-term follow-up data, of both neurodevelopmental and pulmonary outcomes, are urgently needed for proper counseling of mothers.
Conclusion
More than three quarters of infants born at <32 weeks GA after PPROM at previable age survived in this matched cohort study. However, these infants had a higher rate of adverse composite outcome of death, severe neurological injury, severe ROP or CLD than a matched cohort without PPROM. This information may be used to counsel women with previable PPROM who do not develop spontaneous chorioamnionitis or go in to labor. However, long-term follow-up data for surviving infants are urgently needed.
